A study for a 71 year old woman who takes Clonazepam, Losartan Potassium, Armodafinil (an AI-powered real world drug study)

Summary:

771 females aged 71 (±5) who take the same drugs and have adverse effects are studied. This is a phase IV clinical study for a 71 year old female patient who has Anxiety Disorder, High Blood Pressure, Narcolepsy. The study is created by eHealthMe based on reports from sources including the FDA.


On Aug, 20, 2026

771 females aged 71 (±5) who take Clonazepam, Losartan Potassium, Armodafinil and have adverse effects are studied.


Number of reports submitted per year:

Clonazepam, Losartan Potassium, Armodafinil for a 71-year old woman.

Information of the patient in this study:

  • Age: 71
  • Gender: female

What are the drugs?

What are the conditions?

What are the adverse effects?


Comparison with patient's specific adverse outcomes:

You can check what is more associated with an adverse outcome: a drug mix, a drug, a condition, or a population of certain gender and age. Each patient is different. It is not uncommon that the results can be inconclusive or insignificant.

By the same drug(s):

  • Narcolepsy (brain's inability to regulate sleep-wake cycles normally):
    - among females aged 71 (±5) who take the same drugs: 0% (0 of 771)
    - among people who take the same drugs, regardless of gender or age: 0% (0 of 8,991)
  • Anxiety:
    - among females aged 71 (±5) who take the same drugs: 1.82% (14 of 771)
    - among people who take the same drugs, regardless of gender or age: 0.16% (14 of 8,991)
  • Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings):
    - among females aged 71 (±5) who take the same drugs: 0% (0 of 771)
    - among people who take the same drugs, regardless of gender or age: 0% (0 of 8,991)
  • Blood Pressure - High:
    - among females aged 71 (±5) who take the same drugs: 2.33% (18 of 771)
    - among people who take the same drugs, regardless of gender or age: 0.2% (18 of 8,991)

By each condition:

  • people who have Anxiety with Anxiety Disorder:
    - among females aged 71 (±5) who have Anxiety Disorder: 11.73% (95 of 810)
    - among people who have Anxiety Disorder, regardless of gender or age: 10.07% (1,374 of 13,648)
  • people who have Anxiety with High Blood Pressure:
    - among females aged 71 (±5) who have High Blood Pressure: 2.29% (1,845 of 80,468)
    - among people who have High Blood Pressure, regardless of gender or age: 2.56% (15,520 of 605,312)
  • people who have Anxiety with Narcolepsy:
    - among females aged 71 (±5) who have Narcolepsy: 5.11% (61 of 1,194)
    - among people who have Narcolepsy, regardless of gender or age: 8.55% (6,514 of 76,205)
  • people who have Blood Pressure - High with Narcolepsy:
    - among females aged 71 (±5) who have Narcolepsy: 8.71% (104 of 1,194)
    - among people who have Narcolepsy, regardless of gender or age: 7.37% (5,620 of 76,205)
  • people who have Blood Pressure - High with Anxiety Disorder:
    - among females aged 71 (±5) who have Anxiety Disorder: 4.94% (40 of 810)
    - among people who have Anxiety Disorder, regardless of gender or age: 3.46% (472 of 13,648)
  • people who have Blood Pressure - High with High Blood Pressure:
    - among females aged 71 (±5) who have High Blood Pressure: 7.8% (6,279 of 80,468)
    - among people who have High Blood Pressure, regardless of gender or age: 7.4% (44,767 of 605,312)
  • people who have Major Depression with Anxiety Disorder:
    - among females aged 71 (±5) who have Anxiety Disorder: 0.74% (6 of 810)
    - among people who have Anxiety Disorder, regardless of gender or age: 0.29% (40 of 13,648)
  • people who have Major Depression with High Blood Pressure:
    - among females aged 71 (±5) who have High Blood Pressure: 0.01% (9 of 80,468)
    - among people who have High Blood Pressure, regardless of gender or age: 0.05% (306 of 605,312)
  • people who have Major Depression with Narcolepsy:
    - among females aged 71 (±5) who have Narcolepsy: 0.17% (2 of 1,194)
    - among people who have Narcolepsy, regardless of gender or age: 0.38% (290 of 76,205)
  • people who have Narcolepsy with Anxiety Disorder:
    - among females aged 71 (±5) who have Anxiety Disorder: 0% (0 of 810)
    - among people who have Anxiety Disorder, regardless of gender or age: 0.07% (10 of 13,648)
  • people who have Narcolepsy with High Blood Pressure:
    - among females aged 71 (±5) who have High Blood Pressure: 0.02% (14 of 80,468)
    - among people who have High Blood Pressure, regardless of gender or age: 0.01% (66 of 605,312)

By each drug (FDA data only):

  • people who take Clonazepam and have Anxiety:
    - among females aged 71 (±5) who take Clonazepam and have side effects: 5.9% (570 of 9,657)
    - among people who take Clonazepam and have side effects, regardless of gender or age: 6.87% (9,652 of 140,397)
  • people who take Losartan Potassium and have Anxiety:
    - among females aged 71 (±5) who take Losartan Potassium and have side effects: 2.39% (147 of 6,141)
    - among people who take Losartan Potassium and have side effects, regardless of gender or age: 2.5% (1,249 of 50,029)
  • people who take Armodafinil and have Anxiety:
    - among females aged 71 (±5) who take Armodafinil and have side effects: 3.82% (6 of 157)
    - among people who take Armodafinil and have side effects, regardless of gender or age: 8.97% (359 of 4,002)
  • people who take Losartan Potassium and have Blood Pressure - High:
    - among females aged 71 (±5) who take Losartan Potassium and have side effects: 6.53% (401 of 6,141)
    - among people who take Losartan Potassium and have side effects, regardless of gender or age: 6.3% (3,151 of 50,029)
  • people who take Armodafinil and have Blood Pressure - High:
    - among females aged 71 (±5) who take Armodafinil and have side effects: 7.64% (12 of 157)
    - among people who take Armodafinil and have side effects, regardless of gender or age: 6.82% (273 of 4,002)
  • people who take Clonazepam and have Blood Pressure - High:
    - among females aged 71 (±5) who take Clonazepam and have side effects: 4.41% (426 of 9,657)
    - among people who take Clonazepam and have side effects, regardless of gender or age: 4.01% (5,625 of 140,397)
  • people who take Clonazepam and have Major Depression:
    - among females aged 71 (±5) who take Clonazepam and have side effects: 0.09% (9 of 9,657)
    - among people who take Clonazepam and have side effects, regardless of gender or age: 0.22% (306 of 140,397)
  • people who take Losartan Potassium and have Major Depression:
    - among females aged 71 (±5) who take Losartan Potassium and have side effects: 0.05% (3 of 6,141)
    - among people who take Losartan Potassium and have side effects, regardless of gender or age: 0.03% (14 of 50,029)
  • people who take Armodafinil and have Major Depression:
    - among females aged 71 (±5) who take Armodafinil and have side effects: 0% (0 of 157)
    - among people who take Armodafinil and have side effects, regardless of gender or age: 0.32% (13 of 4,002)
  • people who take Clonazepam and have Narcolepsy:
    - among females aged 71 (±5) who take Clonazepam and have side effects: 0.06% (6 of 9,657)
    - among people who take Clonazepam and have side effects, regardless of gender or age: 0.07% (95 of 140,397)
  • people who take Losartan Potassium and have Narcolepsy:
    - among females aged 71 (±5) who take Losartan Potassium and have side effects: 0.02% (1 of 6,141)
    - among people who take Losartan Potassium and have side effects, regardless of gender or age: 0.02% (11 of 50,029)
  • people who take Armodafinil and have Narcolepsy:
    - among females aged 71 (±5) who take Armodafinil and have side effects: 0% (0 of 157)
    - among people who take Armodafinil and have side effects, regardless of gender or age: 0.85% (34 of 4,002)

Common drug interactions *:

  1. Fatigue (feeling of tiredness): 84 people, 10.89%
  2. Fall : 84 people, 10.89%
  3. Dizziness : 74 people, 9.60%
  4. Pain : 68 people, 8.82%
  5. Malaise (a feeling of general discomfort or uneasiness): 56 people, 7.26%
  6. Nausea (feeling of having an urge to vomit): 54 people, 7.00%
  7. Urinary Tract Infection : 52 people, 6.74%
  8. Dyspnea (difficult or laboured breathing): 48 people, 6.23%
  9. Drug Ineffective : 48 people, 6.23%
  10. Diarrhea : 47 people, 6.10%
  11. Weakness : 47 people, 6.10%
  12. Hair Loss : 43 people, 5.58%
  13. Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 41 people, 5.32%
  14. Fever : 41 people, 5.32%
  15. Pneumonia : 41 people, 5.32%
  16. Headache (pain in head): 39 people, 5.06%
  17. Joint Pain : 39 people, 5.06%
  18. Cough : 37 people, 4.80%
  19. Chest Pain : 37 people, 4.80%
  20. Pain In Extremity : 35 people, 4.54%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

  1. High Blood Cholesterol : 78 people, 10.12%
  2. Depression : 77 people, 9.99%
  3. Pain : 76 people, 9.86%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 58 people, 7.52%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 56 people, 7.26%
  6. Insomnia (sleeplessness): 46 people, 5.97%
  7. Parkinson's Disease : 43 people, 5.58%
  8. Arthritis (form of joint disorder that involves inflammation of one or more joints): 42 people, 5.45%
  9. Diabetes : 41 people, 5.32%
  10. Multiple Myeloma (cancer of the plasma cells): 40 people, 5.19%
  11. Sleep Disorder : 35 people, 4.54%
  12. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 35 people, 4.54%
  13. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 33 people, 4.28%
  14. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 33 people, 4.28%
  15. Asthma : 31 people, 4.02%
  16. Cardiac Disorder : 30 people, 3.89%
  17. Immunodeficiency Common Variable : 29 people, 3.76%
  18. Osteoporosis (bones weak and more likely to break): 27 people, 3.50%
  19. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 27 people, 3.50%
  20. Fibromyalgia (a long-term condition which causes pain all over the body): 25 people, 3.24%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

  1. Vitamin D3 (135 people, 17.51%)
  2. Amlodipine (125 people, 16.21%)
  3. Cymbalta (92 people, 11.93%)
  4. Metformin (81 people, 10.51%)
  5. Synthroid (77 people, 9.99%)
  6. Vitamin D (73 people, 9.47%)
  7. Aspirin (70 people, 9.08%)
  8. Nexium (70 people, 9.08%)
  9. Lipitor (69 people, 8.95%)
  10. Prilosec (67 people, 8.69%)
  11. Vitamin C (63 people, 8.17%)
  12. Omeprazole (60 people, 7.78%)
  13. Norco (59 people, 7.65%)
  14. Xyrem (58 people, 7.52%)
  15. Calcium (56 people, 7.26%)
  16. Lyrica (56 people, 7.26%)
  17. Lasix (55 people, 7.13%)
  18. Neurontin (54 people, 7.00%)
  19. Eliquis (51 people, 6.61%)
  20. Gabapentin (51 people, 6.61%)

Drug effectiveness *:

Clonazepam:
  • not at all: 0 %
  • somewhat: 0 %
  • moderate: 0 %
  • high: 0 %
  • very high: 100 %
Losartan Potassium:
  • not at all: 0 %
  • somewhat: 0 %
  • moderate: 0 %
  • high: 100 %
  • very high: 0 %
Armodafinil:

n/a

* Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drug side effects in long term, by gender and age:

Treatments, associated medications and conditions:

Drug side effects:

Drug interactions:

Symptoms:

Drugs that are associated with:

Conditions that are associated with:

How the phase IV clinical study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: